What is the current target price for the Inhibikase Therapeutics Inc share?

The average Inhibikase Therapeutics Inc target price is $15.50. This is 1,031.39% higher than the current share price. The highest price target is 1,578.83%, the lowest is 483.94%. 2 Analysts have issued a price target Inhibikase Therapeutics Inc 2025 .

How high will the Inhibikase Therapeutics Inc share rise?

No reliable answer can be given as to how high the Inhibikase Therapeutics Inc share will rise. The performance of shares, including the Inhibikase Therapeutics Inc share, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Inhibikase Therapeutics Inc share today?

The performance of Inhibikase Therapeutics Inc shares on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Inhibikase Therapeutics Inc share fall?

The decline in Inhibikase Therapeutics Inc shares may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's share price could be in a certain period of time, usually 12 months.

Inhibikase Therapeutics Inc Forecast, price target & analysts

$1.38

0.73% today

Nasdaq, Jun 28, 06:02 pm CET

ISIN

US45719W1062

Symbol

IKT

Reports

Quarter | Year

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Inhibikase Therapeutics Inc Target price 2024 - Analyst rating & recommendation

Inhibikase Therapeutics Inc Classifications & Recommendation:

Buy

100%

Inhibikase Therapeutics Inc Target price

Target price	$15.50
Course	$1.37
Price potential	1,031.39% register free of charge
Number of estimates	2

	2 Analysts have issued a price target Inhibikase Therapeutics Inc 2025 . The average Inhibikase Therapeutics Inc target price is $15.50. This is 1,031.39% register free of charge higher than the current share price. The highest price target is $23.00 1,578.83% register free of charge , the lowest is $8.00 483.94% register free of charge .
	A rating was issued by 2 analysts: 2 Analysts recommend Inhibikase Therapeutics Inc to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst estimates: Analysts believe that the Inhibikase Therapeutics Inc share has an average upside potential 2025 of 1,031.39% register free of charge . Most analysts recommend the Inhibikase Therapeutics Inc share at Purchase.

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '23	2024 Forecast
Earnings per share $	-3.57	-2.33
	16.98%	34.73%
P/E ratio		negative

1 Analysts have issued a Inhibikase Therapeutics Inc forecast for earnings per share. The average Inhibikase Therapeutics Inc <a href=/blog/eps>EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth figures and future valuations:

2023	$-3.57	16.98%
2024	$-2.33 34.73% unlock
2025	$-1.44 38.20% unlock
2026	$-0.93 35.42% unlock
2027	$-0.24 74.19% unlock
2028	$0.96 500.00% unlock

Current	-0.41	30.51%
2024	-0.59 43.90% unlock
2025	-0.95 61.02% unlock
2026	-1.47 54.74% unlock
2027	-5.71 288.44% unlock
2028	1.43 125.04% unlock

Inhibikase Therapeutics Inc...

Discover more stocks with a high price target

Valneva 193.97%

CureVac N.V. 155.92%

Plug Power Inc. 95.95%

Bavarian Nordic 55.50%

Teamviewer 54.84%

Zalando 47.81%

Daimler Truck 46.13%

Alibaba Group Holding Ltd 45.34%

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

Start now